Calculated NOK return from USD · A-AD Shares (NOK Calculated)
Computed from NAV history (price return, NOK, to 16 Nov 2026)
Last NAV 235,44 USD · 16 Nov 2026
Returns by period · NOK · net
ann. 3Y+
+6,2 %
YTD
+5,8 %
1y
+7,4 %
3y, annualised
+5,3 %
5y, annualised
Fund size
209,4 mill. USD
Total fund AUM
Management fee
1,50 %
Annual · class A-AD
Ongoing charge
1,94 %
Annual · class A-AD
Performance fee
None
Stated by the manager
Annual cost on platforms
1,44 %–1,49 %
Class A-AD · 2 platforms · net of platform rebate, incl. platform fee, excl. transaction costs
SFDR
Article 6
Sustainability
Launched
Sept 2018
ISIN LU1775982595
BenchmarkMSCI World Health Care · USD
Risk
Volatility (stated by the manager)15,3 %
Beta0,99
Info Ratio−0,14
Tracking Error5,9 %
About the fund
The fund
Invesco Global Health Care Innovation Fund is an actively managed global equity fund with history going back to 2018. Its management company, Invesco, is a listed American asset manager headquartered in Atlanta, with no majority owner. Its asset management business dates back to 1978.
Investment philosophy
The mandate is aimed at innovative healthcare companies worldwide, with capital growth as the objective.
The managers
Management is shared between Joy Budzinski and Justin Livengood, both based in New York. Budzinski has managed the fund since 2019 and is director of equity research in Invesco's Main Street team, specialising in healthcare. She joined Invesco in 2019 from OppenheimerFunds and was previously healthcare sector manager at Guardian Life. Livengood has managed the fund since 2021. He is senior portfolio manager for Mid Cap Growth and the health care strategies, and joined Invesco in 2019 from OppenheimerFunds, where he had been since 2006.
The portfolio
The fund has fluctuated slightly more than comparable funds.
Fund data is taken from the managers’ own reports, otherwise computed from NAV history and, as a last resort, taken from distributor listings. Not official figures; verify with the fund provider before investing.